Kestra Medical Technologies Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Kestra Medical Technologies, Ltd. (KMTS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2021FY 2020
Period EndingApr 2025Dec 2024Apr 2023Apr 2021Apr 2020
Operating Activities
Net Income-113.81-113.81-84.24-34.10-29.47
Depreciation & Amortization7.977.974.860.420.48
Deferred Income Tax0.060.06-0.050.000.00
Stock Based Compensation24.2724.271.211.860.00
Change in Working Capital-6.20-6.201.30-0.02-2.01
Change in Accounts Receivable-8.78-8.780.000.000.00
Change in Inventory-3.44-3.44-0.730.000.00
Change in Accounts Payable2.842.842.14-0.13-0.79
Change in Other Working Capital3.183.186.721.90-1.22
Other Operating Activities3.9810.116.721.900.70
Net Cash from Operating Activities-77.61-77.61-69.64-29.90-30.29
Investing Activities
Capital Expenditures-23.59-23.59-15.46-0.34-0.23
Other Investing Activities0.280.280.000.000.00
Net Cash from Investing Activities-23.31-23.31-15.46-0.33-0.23
Financing Activities
Debt Repayment0.000.00-5.330.000.00
Common Stock Issued218.16215.790.0030.3330.42
Dividends Paid-1.65-1.65-0.67-0.190.00
Other Financing Activities8.70116.13-0.6729.00-0.18
Net Cash from Financing Activities330.26330.2696.1148.8230.24
Summary
Net Change in Cash229.35229.3511.0018.59-0.29
Cash at Beginning of Period8.588.584.326.270.00
Cash at End of Period237.93237.9315.3224.850.00
Free Cash Flow-101.20-101.20-85.10-30.23-30.53
Supplemental Disclosures
Interest Paid4.853.630.000.000.00
Income Taxes Paid0.08-0.030.010.210.07